InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
DNA synthesis inhibitor | Biomimetic cell membrane-coated DNA nanoparticles for gene delivery to gliobl... | 2021 | J Control Release | Han S. et al. | DOI: 10.1016/j.jconrel.2021.08.021 |
RAW-Blue™ Cells | Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in ... | 2021 | J Med Chem. | Facchini F.A. et al. | DOI: 10.1021/acs.jmedchem.1c00896 |
PMA - Phorbol myristate acetate | Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in ... | 2021 | J Med Chem. | Facchini F.A. et al. | DOI: 10.1021/acs.jmedchem.1c00896 |
Pam2CSK4 | Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in ... | 2021 | J Med Chem. | Facchini F.A. et al. | DOI: 10.1021/acs.jmedchem.1c00896 |
Human TLR4 Reporter HEK293 Cells (NF-κB) | Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in ... | 2021 | J Med Chem. | Facchini F.A. et al. | DOI: 10.1021/acs.jmedchem.1c00896 |
Human TLR2 Reporter HEK293 Cells (NF-κB) | Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in ... | 2021 | J Med Chem. | Facchini F.A. et al. | DOI: 10.1021/acs.jmedchem.1c00896 |
ISD | Brucella spp. Omp25 Promotes Proteasome-Mediated cGAS Degradation to Attenuat... | 2021 | Front Microbiol. | Li R. et al. | DOI: 10.3389/fmicb.2021.702881 |
2'3'-cGAMP | Brucella spp. Omp25 Promotes Proteasome-Mediated cGAS Degradation to Attenuat... | 2021 | Front Microbiol. | Li R. et al. | DOI: 10.3389/fmicb.2021.702881 |
Puromycin | Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR ... | 2021 | Cancer Immunol Res. | Xia L. et al. | DOI: 10.1158/2326-6066.CIR-20-0405 |
PlasmoTest™ - Mycoplasma Detection Kit | Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR ... | 2021 | Cancer Immunol Res. | Xia L. et al. | DOI: 10.1158/2326-6066.CIR-20-0405 |
Amlexanox | STING agonist-based treatment promotes vascular normalization and tertiary ly... | 2021 | J Immunother Cancer | Chelvanambi M. et al. | DOI: 10.1136/jitc-2020-001906 |
Amlexanox | Annexin-A1 promotes RIG-I-dependent signaling and apoptosis via regulation of... | 2020 | Cell Death Dis. | Yap G.L.R. et al. | DOI: 10.1038/s41419-020-2625-7 |
Pepinh-MYD | Integration of T helper and BCR signals governs enhanced plasma cell differen... | 2021 | Cell Rep. | Szodoray P. et al. | DOI: 10.1016/j.celrep.2021.109525 |
ODN 2006 (ODN 7909) | Integration of T helper and BCR signals governs enhanced plasma cell differen... | 2021 | Cell Rep. | Szodoray P. et al. | DOI: 10.1016/j.celrep.2021.109525 |
Human TLR1-9 Agonist kit | Integration of T helper and BCR signals governs enhanced plasma cell differen... | 2021 | Cell Rep. | Szodoray P. et al. | DOI: 10.1016/j.celrep.2021.109525 |
LPS-PG (Lipopolysaccharide from P. gingivalis) | Role of ascorbic acid in the regulation of epigenetic processes induced by Po... | 2021 | Histochem Cell Biol | Pizzicannella J. et al. | DOI: 10.1007/s00418-021-02014-8 |
Anti-PD-L1 (Atezolizumab biosimilar - IgG1 (N298A) isotype) | Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inh... | 2021 | J Immunother Cancer | Hamdan F. et al. | DOI: 10.1136/jitc-2021-003000 |
Anti-PD-L1 (Atezolizumab biosimilar - IgG1 isotype) | Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inh... | 2021 | J Immunother Cancer | Hamdan F. et al. | DOI: 10.1136/jitc-2021-003000 |
Imiquimod (R837) | Inflammasome-induced extracellular vesicles harbour distinct RNA signatures a... | 2021 | J Extracell Vesicles | Budden C.F. et al. | DOI: 10.1002/jev2.12127 |
Pam3CSK4 | Inflammasome-induced extracellular vesicles harbour distinct RNA signatures a... | 2021 | J Extracell Vesicles | Budden C.F. et al. | DOI: 10.1002/jev2.12127 |